| 04/11/2013 | Nodality, Inc. Announces Data Presentations at AACR 2013 Annual Meeting |
| 04/09/2013 | Nodality, Inc. Announces Expansion of Company's Patent Estate Covering Programs to Improve the Treatment of Patients with Severe Diseases in Immunology, Oncology, and Autoimmune Diseases |
| 03/04/2013 | Nodality, Inc. Expands Senior Team, Appoints Guy Cavet, Ph.D., as Chief Information Officer, Head of Computational Sciences |
| 09/24/2012 | Nodality, Inc. Appoints Laura Brege as Chief Executive Officer |
| 08/09/2012 | Nodality Enters into a Multi-Year Strategic Collaboration with Pfizer in Autoimmune Disease |
| 07/24/2012 | Nodality Receives Three Key US Patents in Oncology and Autoimmune Diseases |
| 07/17/2012 | Nodality, Inc. Raises $15M in New Funding |
| 06/28/2012 | Nodality, Inc. Receives CLIA Certification for its Clinical Laboratory |
| 02/10/2012 | Nodality and UCB Enter into a Multi-Year Strategic Collaboration |
| 08/01/2011 | Nodality, Inc. Appoints Daniel Dornbusch as Vice President of Business Development |
| 06/01/2011 | Nodality, Inc. Appoints Michael Goldberg as Executive Chairman of the Board of Directors |
| 01/24/2011 | Nodality Takes Top Honors as “Most Promising Company” at the Personalized Medicine World Conference 2011 |
| 12/13/2010 | Nodality Appoints Dr. Greg Critchfield to Board of Directors |
| 12/07/2010 | Nodality Showcases Novel, Proprietary Technology to Predict Response to Therapy and Relapse Risk in Cancer Patients |
| 11/29/2010 | Nodality Announces Presentations at 2010 ASH, Including Key Findings in Acute Myeloid Leukemia (AML) and Chronic Lymphocytic Leukemia (CLL) |
| 07/16/2010 | Nodality and Celgene Form Drug Development Collaboration |
| 03/22/2010 | Nodality Completes $15.5 Million in Financing |
| 11/30/2009 | Nodality Announces Data Presentations at 2009 ASH |
| 03/16/2009 | Nodality Completes Series B Financing |
| 09/24/2007 | Nodality Names David R. Parkinson, M.D. as Its CEO |
| 02/01/2007 | Nodality Raises Series A Financing |
